readthroughSign in
Jul 15, 2026Partnership

Prestige Brands issues $400 million in senior notes due 2034

The Prestige Consumer Healthcare subsidiary priced 6.250% notes in a private offering, with proceeds terms and redemption rights set out in the indenture.

On July 15, 2026, Prestige Brands, Inc., a wholly owned subsidiary of Prestige Consumer Healthcare Inc., issued $400.0 million aggregate principal amount of 6.250% senior notes due 2034 pursuant to an indenture among Prestige Brands, the guarantors including the company, and U.S. Bank Trust Company, National Association, as trustee.1

The notes carry a fixed schedule for payments. Interest will be payable on January 15 and July 15 of each year, starting January 15, 2027, until the notes mature on July 15, 2034.1 The notes are senior unsecured obligations of Prestige Brands, guaranteed on an unsecured senior basis by the company and certain of its existing and future domestic restricted subsidiaries.1

Redemption terms give Prestige Brands flexibility over time. The company can redeem all or part of the notes on or after July 15, 2029, at redemption prices set in the indenture, plus accrued and unpaid interest.1 Before that date, it may redeem the notes at 100% of principal plus a make-whole premium and accrued interest.1 It may also redeem up to 40% of the notes before July 15, 2029 using proceeds from certain equity offerings, subject to conditions.1 In a change of control, Prestige Brands must offer to repurchase the notes at 101% of principal plus accrued interest.1

The indenture also imposes standard restrictions. Covenants limit the company's and certain subsidiaries' ability to take on new debt, pay dividends or buy back stock, make other restricted payments, incur liens, redeem junior debt, dispose of assets, merge, or enter into affiliate transactions.1

The notes were sold in a private offering exempt from Securities Act registration, to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S.1

Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.